Qumulo Expands Lead in Media and Entertainment
Significant global increase in file data needs fuels customer adoption and extends depth and breadth…
Significant global increase in file data needs fuels customer adoption and extends depth and breadth…
Top AI Delivery Partner Quantiphi to be first UJET Certified Delivery Partner SAN FRANCISCO–(BUSINESS WIRE)–UJET,…
Through its Amazon Future Engineer program, the company will award $10 million in $40,000 scholarships…
DENVER–(BUSINESS WIRE)–Alyve Medical, Inc. (formerly NCS America, Inc.), a global medical technology company and leader…
ST. PETERSBURG, Fla.–(BUSINESS WIRE)–Ahmie Baum, Founder and CEO of Interchange Capital Partners announced today that…
Perfect Corp.’s new trend report spotlights a shift in focus to low-maintenance hair routines, natural…
LOS ANGELES–(BUSINESS WIRE)–Westlake Financial (WF) and Western Funding (WFI) are now funding deals to their…
WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health announced that its medical research platform, Ovid®, now offers access…
DETROIT–(BUSINESS WIRE)–Altimetrik, a leading digital business enablement company, today announced that Rajesh Ananth has been…
Mek will bring unique HHS cybersecurity, AI and blockchain experience to Equideum Health He will…
LeapYear study focuses on areas where trading desks can create competitive differentiation SAN FRANCISCO–(BUSINESS WIRE)–Now…
– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a…
Data Continue to Highlight the Potential of ALLO-316 to Treat Both Solid Tumors and Hematologic…
Dr. Medarova will present at the 3rd Annual RNAi-Based Therapeutics Summit on April 20 BOSTON,…
New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13 SOLANA BEACH, Calif.,…
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2…
Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis”…
Urvashi Patel, Ph.D., as Vice President, Regulatory Affairs Stacey Bilinski, as Vice President, Clinical Operations…
Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcoma Resources will be primarily…
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company…